97 related articles for article (PubMed ID: 27712706)
1. Impact of Treatment Subsidies and Cash Payouts on Treatment Choices at the End of Life.
Finkelstein E; Malhotra C; Chay J; Ozdemir S; Chopra A; Kanesvaran R
Value Health; 2016; 19(6):788-794. PubMed ID: 27712706
[TBL] [Abstract][Full Text] [Related]
2. Comparison of preferences for end-of-life care among patients with advanced cancer and their caregivers: A discrete choice experiment.
Malhotra C; Farooqui MA; Kanesvaran R; Bilger M; Finkelstein E
Palliat Med; 2015 Oct; 29(9):842-50. PubMed ID: 25805740
[TBL] [Abstract][Full Text] [Related]
3. Preferences for end-of-life care among community-dwelling older adults and patients with advanced cancer: A discrete choice experiment.
Finkelstein EA; Bilger M; Flynn TN; Malhotra C
Health Policy; 2015 Nov; 119(11):1482-9. PubMed ID: 26421597
[TBL] [Abstract][Full Text] [Related]
4. Measuring Preferences for a Diabetes Pay-for-Performance for Patient (P4P4P) Program using a Discrete Choice Experiment.
Chen TT; Tung TH; Hsueh YS; Tsai MH; Liang HM; Li KL; Chung KP; Tang CH
Value Health; 2015 Jul; 18(5):578-86. PubMed ID: 26297085
[TBL] [Abstract][Full Text] [Related]
5. Place of Care at End of Life: What Factors Are Associated With Patients' and Their Family Members' Preferences?
Loh AZ; Tan JS; Jinxuan T; Lyn TY; Krishna LK; Goh CR
Am J Hosp Palliat Care; 2016 Aug; 33(7):669-77. PubMed ID: 25900855
[TBL] [Abstract][Full Text] [Related]
6. Valuing health at the end of life: a stated preference discrete choice experiment.
Shah KK; Tsuchiya A; Wailoo AJ
Soc Sci Med; 2015 Jan; 124():48-56. PubMed ID: 25461861
[TBL] [Abstract][Full Text] [Related]
7. Household preferences for cataract surgery in rural India: a population-based stated preference survey.
Radhakrishnan M; Venkatesh R; Valaguru V; Frick KD
Ophthalmic Epidemiol; 2015 Feb; 22(1):34-42. PubMed ID: 24067063
[TBL] [Abstract][Full Text] [Related]
8. Quality of life changes and intensive care preferences in terminal cancer patients.
Hwang IC; Keam B; Yun YH; Ahn HY; Kim YA
Palliat Support Care; 2015 Oct; 13(5):1309-16. PubMed ID: 25376378
[TBL] [Abstract][Full Text] [Related]
9. Eliciting preferences to inform patient-centred policies: the case of psoriasis.
Torbica A; Fattore G; Ayala F
Pharmacoeconomics; 2014 Feb; 32(2):209-23. PubMed ID: 24446282
[TBL] [Abstract][Full Text] [Related]
10. Measuring High-Risk Patients' Preferences for Pharmacogenetic Testing to Reduce Severe Adverse Drug Reaction: A Discrete Choice Experiment.
Dong D; Ozdemir S; Mong Bee Y; Toh SA; Bilger M; Finkelstein E
Value Health; 2016; 19(6):767-775. PubMed ID: 27712704
[TBL] [Abstract][Full Text] [Related]
11. Assessing the value of symptom relief for patients with gastroesophageal reflux disease treatment: willingness to pay using a discrete choice experiment.
Deal K; Marshall D; Dabrowski D; Charter A; Bukoski M; Moayyedi P
Value Health; 2013 Jun; 16(4):588-98. PubMed ID: 23796293
[TBL] [Abstract][Full Text] [Related]
12. Are life-extending treatments for terminal illnesses a special case? Exploring choices and societal viewpoints.
McHugh N; van Exel J; Mason H; Godwin J; Collins M; Donaldson C; Baker R
Soc Sci Med; 2018 Feb; 198():61-69. PubMed ID: 29276987
[TBL] [Abstract][Full Text] [Related]
13. Quality versus quantity in end-of-life choices of cancer patients and support persons: a discrete choice experiment.
Waller A; Sanson-Fisher R; Brown SD; Wall L; Walsh J
Support Care Cancer; 2018 Oct; 26(10):3593-3599. PubMed ID: 29725803
[TBL] [Abstract][Full Text] [Related]
14. Palliative chemotherapy preferences and factors that influence patient choice in incurable advanced cancer.
Kim MK; Lee JL; Hyun MS; Do YR; Song HS; Kim JG; Bae SH; Ryoo HM; Park KU; Lee KH
Jpn J Clin Oncol; 2008 Jan; 38(1):64-70. PubMed ID: 18238880
[TBL] [Abstract][Full Text] [Related]
15. Societal preferences for rheumatoid arthritis treatments: evidence from a discrete choice experiment.
Harrison M; Marra C; Shojania K; Bansback N
Rheumatology (Oxford); 2015 Oct; 54(10):1816-25. PubMed ID: 25989956
[TBL] [Abstract][Full Text] [Related]
16. Socioeconomic differences in preferences and willingness-to-pay for insulin delivery systems in type 1 and type 2 diabetes.
Guimarães C; Marra CA; Colley L; Gill S; Simpson S; Meneilly G; Queiroz RH; Lynd LD
Diabetes Technol Ther; 2009 Sep; 11(9):567-73. PubMed ID: 19764835
[TBL] [Abstract][Full Text] [Related]
17. Should I stay or should I go home? A latent class analysis of a discrete choice experiment on hospital-at-home.
Goossens LM; Utens CM; Smeenk FW; Donkers B; van Schayck OC; Rutten-van Mölken MP
Value Health; 2014 Jul; 17(5):588-96. PubMed ID: 25128052
[TBL] [Abstract][Full Text] [Related]
18. Patient preferences for depression treatment programs and willingness to pay for treatment.
Morey E; Thacher JA; Craighead WE
J Ment Health Policy Econ; 2007 Jun; 10(2):73-85. PubMed ID: 17603148
[TBL] [Abstract][Full Text] [Related]
19. Using discrete choice experiments to understand preferences in health care.
Pfarr C; Schmid A; Schneider U
Dev Health Econ Public Policy; 2014; 12():27-48. PubMed ID: 24864381
[TBL] [Abstract][Full Text] [Related]
20. Preferences for Aggressive End-of-life Care and Their Determinants Among Taiwanese Terminally Ill Cancer Patients.
Liu LN; Chen CH; Liu TW; Lin YC; Lee SC; Tang ST
Cancer Nurs; 2015; 38(3):E9-E18. PubMed ID: 24915466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
